Episode 045: Myeloma Series, Pt.6- Myeloma Treatment in Transplant Ineligible Patients
The Fellow on Call: The Heme/Onc Podcast
00:00
The Role of Quadriplet Therapy in Transplant Ineligibility
We talked a little bit about quadriplet therapy in our last episode as well. If you have something that's going to have less toxicity, why would anybody reach for the one with more toxicity? That kind of set the stage for where we are now in today's era. You'll see when Dan talks about his trial that got this daratumumab, dexamethasone-approved, daratummab, their control arm in that trial was RD, not VRD.
Transcript
Play full episode
